Regeneron Pharmaceuticals REGN Unveils C5 Complement Pipeline Strategy But Execution Risks Cap NearTerm Upside CVSA Covista delivers 89 percent first quarter 2026 EPS beat shares rise modestly on upbeat investor reaction Centene Corporation CNC Valuation Assessment Following Recent ShortTerm Share Price Rebound LPTH LightPath Technologies gains 10 percent in daily trading even as Q1 2026 earnings sharply miss analyst expectations Is Rein Therapeutics RNTX stock testing important levels Q4 2025 Profit Disappoints